COO Q4 2024 Earnings — The Cooper Companies, Inc. Revenue & Financial Results | Market Cap Arena

COOThe Cooper Companies, Inc.

$15B

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.0B+9.8% YoY

Gross Profit

$678M66.5% margin

Operating Income

$198M19.5% margin

Net Income

$118M11.5% margin

EPS (Diluted)

$0.58

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$268M

Free Cash Flow

$128M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$12.3B

Total Liabilities

$4.2B

Stockholders' Equity

$8.1B

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$927M	+9.8%
Gross Profit	$678M	$607M	+11.7%
Operating Income	$198M	$136M	+46.2%
Net Income	$118M	$85M	+39.1%

Revenue Segments

Coopervision Segment

$676M66%

Coopersurgical Segment

$342M34%

Geographic Segments

Europe

$1.4B51%

UNITED STATES

$1.1B41%

Rest Of World, Excluding United States And Europe

$208M8%